Ultragenyx CEO talks the company’s path to profitability in developing drugs for rare diseases
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
Share
Dr. Emil Kakkis, Ultragenyx founder & CEO, joins ‘Closing Bell Overtime’ to talk drug trials and development, its path to profitability and more.
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email Detlev Von Platen, Porsche Cars North America talks to CNBC’s Phil LeBeau about the luxury automaker’s newest sports model. 02:17 Mon, Jan 11 20166:30 AM EST
ShareShare Article via FacebookShare Article via TwitterShare Article via LinkedInShare Article via Email NBC’s Bill Neely reports analyst in South Korea confirmed there was a test but it could take weeks or months to determine what exactly happened underground. 02:21 Wed, Jan 6 20166:03 AM EST
A New York City cowboy boot store may sell classic styles, but it’s been improving its sales by using technology and analytics on the Bindo POS iPad app.
CNBC’s Jim Cramer said investors should usually wait until high-quality stocks have had a pullback before buying. But sometimes it’s worth buying some stock at the top, especially if a company engages in significant insider buying. Not to be confused with insider trading, insider buying is based on public information and occurs when executives buy…
The final call of the day with the ‘Options Action’ traders.
Shanette’s dream home has become a financial nightmare. She’s come to Suze to ask for advice on how to get back on track.